Condition
Post-ET Myelofibrosis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Post-ET Myelofibrosis clinical trials that are recruiting, at sites in 19 countries (most in France (2), Germany (2), Italy (2)). By phase: Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 19Countries
All recruiting trials (2)
-
Adding navtemadlin to ruxolitinib for myelofibrosis patients with poor response
This study is testing if adding a new drug called navtemadlin to ruxolitinib can help myelofibrosis patients who aren't doing well on ruxolitinib alone.
-
Combining TL-895 with Ruxolitinib for treating Myelofibrosis
This study is testing if combining TL-895 with Ruxolitinib can help people with Myelofibrosis feel better, especially those who haven't responded well to Ruxolitinib alone.
Related topics
Quick answers
How many Post-ET Myelofibrosis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in France (2 trials), Germany (2 trials), Italy (2 trials), Poland (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.